- FoI Number
- 2024-031
- Subject
- Cancer Treatment
- Date Received
- 11/04/2024
- Request and Response
-
Where the specified Nov 23 – March 24 timeframe is not possible to provide, could you please provide the latest 5 months of data you have, and specify which timeframe this covers.
- How many unique total patients were treated in the last 5 months (Nov 23 – March 24) with Durvalumab for the following indications?
- Biliary Tract Cancer
- Non-Small Cell Lung Cancer
How many unique total patients were treated in the last 5 months (Nov 23 – March 24) with Nivolumab for early stage (resectable) non-small cell lung cancer (Stages 1 – 3b)?
- How many unique total patients were treated last month (March 24) with Durvalumab for the following indications?
- Biliary Tract Cancer
- Non-Small Cell Lung Cancer
- How many patients received their first treatment in the last 5 months (Nov 23 – March 24) with Durvalumab for the following indications?
- Biliary Tract Cancer
- Non-Small Cell Lung Cancer
The answer to all questions is ZERO
